Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Musk Wants To Delay Twitter Trial

News

Musk Wants To Delay Twitter Trial

– Reuters Citing Court Records

byBenzinga Newsdesk

August 30, 2022

1 minute read

– Reuters Citing Court Records

Morgan Stanley Maintains Equal-Weight on U.S. Bancorp, Lowers Price Target to $55

By Benzinga Newsdesk

December 6, 9:46 AM

Morgan Stanley analyst Betsy Graseck maintains U.S. Bancorp (NYSE:USB) with a Equal-Weight and lowers the price target from $57 to $55.

USB

JMP Securities Maintains Market Outperform on Blue Owl Cap, Lowers Price Target to $17

By Benzinga Newsdesk

October 11, 8:09 AM

JMP Securities analyst Devin Ryan maintains Blue Owl Cap (NYSE:OWL) with a Market Outperform and lowers the price target from $18 to $17.

OWL

SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes

By Vuk Zdinjak

September 22, 12:03 PM

SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisional patent application related to metabolic syndromes including obesity, regarding the company's collaboration with Clearmind.

CMNDF

Reed’s Q2 EPS $(0.05) Down From $(0.04) YoY, Sales $13.72M Miss $14.37M Estimate

By Michael Horton

Today, 5:10 PM

Reed's (NASDAQ:REED) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $13.72 million

REED

Musk Wants To Delay Twitter Trial

Related Posts

Morgan Stanley Maintains Equal-Weight on U.S. Bancorp, Lowers Price Target to $55

JMP Securities Maintains Market Outperform on Blue Owl Cap, Lowers Price Target to $17

SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes

Reed’s Q2 EPS $(0.05) Down From $(0.04) YoY, Sales $13.72M Miss $14.37M Estimate